trial summary · NCT07615049
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma
Trial record from the TrialBase DB dataset, status RECRUITING, condition Recurrent Soft Tissue Sarcoma of the Trunk and Extremities, sponsored by SWOG Cancer Research Network. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to standard-course radiation therapy over 25 days (RT-25) in treating patients with soft tissue sarcomas of the extremities that may be primary or that may have come back to nearby tissue or lymph nodes after a period of improvement (locally recurrent) and that can be removed by surgery (resectable). Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. 3-dimensional (3D) conformal radiation therapy (CRT) uses a computer to create a 3D picture of the tumor. This allows doctors to give the highest possible dose of radiation to the tumor, while sparing the normal tissue as much as possible. Intensity-modulated radiation therapy (IMRT) is a type of 3D radiation therapy that uses computer-generated images to show the size and shape of the tumor. Thin beams of radiation of different intensities are aimed at the tumor from many angles. This type of radiation therapy reduces the damage to healthy tissue near the tumor. Standard-course (fractionated) radiation divides the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days. Ultrahypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Giving UHRT-5 may be as effective as RT-25 in treating patients with primary or locally recurrent soft tissue sarcomas of the extremities that are resectable. It …
Source record: https://clinicaltrials.gov/study/NCT07615049
Facts
| registry id | NCT07615049 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE3 |
| study type | INTERVENTIONAL |
| lead condition | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities |
| sponsor | SWOG Cancer Research Network |
| sponsor class | NETWORK |
| enrollment | 296 |
| start date | 2026-12-02 |
| primary completion | 2029-04-30 |
| completion | 2030-04-30 |
| results posted | not reported |
Conditions
- Recurrent Soft Tissue Sarcoma of the Trunk and Extremities
- Resectable Soft Tissue Sarcoma of the Trunk and Extremities
- Soft Tissue Sarcoma of the Trunk and Extremities
- Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
- Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Interventions
- 3-Dimensional Conformal Radiation Therapy
- Biospecimen Collection
- Computed Tomography
- Intensity-Modulated Radiation Therapy
- Magnetic Resonance Imaging
- Surgical Procedure
Countries
- United States
Intervention types: PROCEDURE, RADIATION
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.